Corneal Neovascularization as a Target for Nucleotide-Based Therapies

Yi-Jen Hsueh^1,2#, Hung-Chi Chen^1,2,3#, Jui-Yang Lai^4,5, Jan-Kan Chen⁶ and David Hui-Kang Ma^1,2,7*

¹Limbal Stem Cell Laboratory, Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan

²Center for Tissue Engineering, Chang Gung Memorial Hospital, Taoyuan, Taiwan

³Department of Medicine, Chang Gung University College of Medicine, Taoyuan, Taiwan

⁴Institute of Biochemical and Biomedical Engineering, Chang Gung University, Taoyuan, Taiwan

⁵Biomedical Engineering Research Center, Chang Gung University, Taoyuan, Taiwan

⁶Department of Physiology, College of Medicine, Chang Gung University, Taoyuan, Taiwan

⁷Department of Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan

^#Contributed equally to this work

^*Corresponding Author: David Hui-Kang Ma, MD, PhD, Stem Cell Laboratory of Ophthalmology, Chang Gung Memorial Hospital, No. 5, Fuxing St., Guishan, Taoyuan 33305, Taiwan, Tel: +886-3-3281200 Exn. 8652, Fax: +886-3-3287798 Email: